SCHEMBL29469849

SCHEMBL29469849

NS(=O)(=O)c1c(F)cccc1C1CCC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
PKM P14618 1/20 0.40
PKLR P30613 1/20 0.40
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
HTR2C P28335 2/20 0.37
HTR2B P41595 2/20 0.37
PTGS2 P35354 1/20 0.37
KDM1A O60341 2/20 0.37
KDM1B Q8NB78 1/20 0.37
CA12 O43570 2/20 0.37
PTGES2 Q9H7Z7 1/20 0.37
CA9 Q16790 1/20 0.37
CA7 P43166 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20502275 0.93 PKM (0.42) NOS3NOS1NOS2PKMPKLR
SCHEMBL30605922 0.93 PKM (0.42) NOS3NOS1NOS2PKMPKLR
SCHEMBL20674413 0.78 PTGES2 (0.43) CA1CA2PTGS2CA12PTGES2
SCHEMBL29469840 0.77 HTR2C (0.40) CA1CA2HTR2CHTR2BPTGS2
SCHEMBL1531218 0.75 PTGS2 (0.42) CA1CA2HTR2CHTR2BPTGS2
SCHEMBL677588 0.75 CA1 (0.52) PKMPKLRCA1CA2CA12
SCHEMBL29469904 0.73 SLC6A2 (0.40) PKMPKLRHTR2CPTGES2
SCHEMBL28562885 0.72 ACMSD (0.43) PKMCA1CA2PTGS2CA12
SCHEMBL434672 0.72 KDM4E (0.50) NOS3NOS1NOS2HTR2CHTR2B
SCHEMBL5032032 0.72 PTGES2 (0.46) CA1CA2PTGS2CA12PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed